Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-028638
Filing Date
2024-12-09
Accepted
2024-12-09 16:15:16
Documents
1
Period of Report
2024-12-05

Document Format Files

Seq Description Document Type Size
1 form4-12092024_041211.html 4  
1 form4-12092024_041211.xml 4 7903
  Complete submission text file 0001415889-24-028638.txt   9324
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Issuer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O NEXTECH INVEST LTD. BAHNHOFSTRASSE 18 ZURICH V8 8001
Business Address
Schroeder Thilo (Reporting) CIK: 0001776412 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39219 | Film No.: 241535286